Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Emma J A Schepens"'
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0295911 (2024)
Objective olfactory function can be assessed using validated olfactory tests like the Sniffin' Sticks Test (SST). However, their extensive nature makes them less suitable for clinical practice. To address this, shorter olfactory tests like the screen
Externí odkaz:
https://doaj.org/article/810be2e991d94f5c931dc09ee9dba0fc
Autor:
Sanne Boesveldt, Inge Stegeman, Robert J Stokroos, Digna M A Kamalski, Emma J A Schepens, Wilbert M Boek
Publikováno v:
BMJ Open, Vol 12, Iss 8 (2022)
Introduction Hyposmia and anosmia are common in COVID-19. Most patients regain normal smell within 4 weeks, but severe loss of smell persists roughly in 20% after 2 months and may last up to a year or longer. These persistent smell disorders greatly
Externí odkaz:
https://doaj.org/article/5c34e4aeff6e487aa8cf1312d7cd4acc
Autor:
Emma J. A. Schepens, Esther E. Blijleven, Wilbert M. Boek, Sanne Boesveldt, Robert J. Stokroos, Inge Stegeman, Digna M. A. Kamalski
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Background Prednisolone has been suggested as a treatment for olfactory disorders after COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral prednisolone treatment on patients with persistent olfactory
Externí odkaz:
https://doaj.org/article/e2dcf5f27c1742afabf69b447844d791
Autor:
Emma J. A. Schepens, Esther E. Blijleven, Wilbert M. Boek, Sanne Boesveldt, Robert J. Stokroos, Inge Stegeman, Digna M. A. Kamalski
Publikováno v:
BMC Medicine, 21(1)
BMC Medicine 21 (2023) 1
BMC Medicine 21 (2023) 1
The original article [1] contained the following errors with their respective amendments: 1) Abstract, lines 48 and 49: “Median TDI score on SST was 26.8 (IQR 23.6-29.3) in the placebo group and 28.8 (IQR 24.0-30.9) in the prednisolone group, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50745fdb6d0aabeff8e338148af7da2
https://research.wur.nl/en/publications/correction-prednisolone-does-not-improve-olfactory-function-after
https://research.wur.nl/en/publications/correction-prednisolone-does-not-improve-olfactory-function-after
Autor:
Emma J A, Schepens, Wilbert M, Boek, Sanne, Boesveldt, Inge, Stegeman, Robert J, Stokroos, Digna M A, Kamalski
Publikováno v:
BMJ open. 12(8)
Hyposmia and anosmia are common in COVID-19. Most patients regain normal smell within 4 weeks, but severe loss of smell persists roughly in 20% after 2 months and may last up to a year or longer. These persistent smell disorders greatly influence dai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7afc74b45b88c51ea81065820b55da7f
https://pubmed.ncbi.nlm.nih.gov/35948382
https://pubmed.ncbi.nlm.nih.gov/35948382
Autor:
Emma J A Schepens, Wilbert M Boek, Sanne Boesveldt, Inge Stegeman, Robert J Stokroos, Digna M A Kamalski
Publikováno v:
BMJ Open 12 (2022) 8
BMJ Open, 12(8)
BMJ open, 12(8):060416. BMJ Publishing Group
BMJ Open, 12(8)
BMJ open, 12(8):060416. BMJ Publishing Group
IntroductionHyposmia and anosmia are common in COVID-19. Most patients regain normal smell within 4 weeks, but severe loss of smell persists roughly in 20% after 2 months and may last up to a year or longer. These persistent smell disorders greatly i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8850a3b6f4f988d4cebd8bcbbb10edd
https://doi.org/10.1136/bmjopen-2021-060416
https://doi.org/10.1136/bmjopen-2021-060416
Autor:
Emma J. A. Schepens, Wilbert M. Boek, Sanne Boesveldt, Robert J. Stokroos, Inge Stegeman, Digna M. A. Kamalski
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Background Olfactory disorders are common in COVID-19. While many patients recover within weeks, a notable number of patients suffer from prolonged olfactory disorders. Much research has focused on the acute phase of olfactory disorders in C
Externí odkaz:
https://doaj.org/article/ddd37a7df6d24d71bc428171370bc22d